Aviso: Este sitio agrega datos públicos oficiales de la FDA, ClinicalTrials.gov, PubMed y SEC EDGAR solo como referencia general. No constituye asesoramiento médico, diagnóstico, recomendaciones de tratamiento ni asesoramiento de inversión.

PMA de la FDA

System, test, tumor marker, for detection of bladder cancer

Número de PMA: P940035 · 2022-07-12

SolicitanteAbbott Diagnostics Scarborough, Inc.
Fecha de decisión2022-07-12
Número PMAP940035
Código de productoNAH
Clase del dispositivoClase 3
Especialidad médicaU
Comité asesorIM

Resumen del dispositivo

System, test, tumor marker, for detection of bladder cancer is the device name listed in this FDA 510(k) record. The listed applicant is Abbott Diagnostics Scarborough, Inc.. It received FDA 510(k) clearance on 2022-07-12. The device is classified under product code NAH. It was reviewed by the IM advisory panel.

Preguntas frecuentes

What is the System, test, tumor marker, for detection of bladder cancer?

System, test, tumor marker, for detection of bladder cancer is a medical device that received FDA 510(k) clearance on 2022-07-12. The listed applicant is Abbott Diagnostics Scarborough, Inc..

When did System, test, tumor marker, for detection of bladder cancer receive FDA 510(k) clearance?

The clearance date for System, test, tumor marker, for detection of bladder cancer can be found in the official FDA records.

Who is the listed applicant for System, test, tumor marker, for detection of bladder cancer?

The FDA 510(k) record lists Abbott Diagnostics Scarborough, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for System, test, tumor marker, for detection of bladder cancer?

The FDA product code for System, test, tumor marker, for detection of bladder cancer is NAH.

Ensayos clínicos relacionados

Los registros relacionados se emparejan automáticamente mediante nombres, códigos de producto u otros metadatos. Un emparejamiento no establece una relación clínica, científica, corporativa o regulatoria verificada; revise las fuentes oficiales enlazadas.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Fuente oficial

Ver en la base de datos de la FDA →

Datos procedentes de la API abierta de la FDA. Para obtener la información más actualizada y autoritativa, consulte siempre el registro oficial.

↑